1. Home
  2. XELB vs INDP Comparison

XELB vs INDP Comparison

Compare XELB & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • INDP
  • Stock Information
  • Founded
  • XELB 2011
  • INDP 2000
  • Country
  • XELB United States
  • INDP United States
  • Employees
  • XELB N/A
  • INDP N/A
  • Industry
  • XELB Multi-Sector Companies
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • INDP Health Care
  • Exchange
  • XELB Nasdaq
  • INDP Nasdaq
  • Market Cap
  • XELB 4.6M
  • INDP 5.0M
  • IPO Year
  • XELB N/A
  • INDP N/A
  • Fundamental
  • Price
  • XELB $1.91
  • INDP $11.12
  • Analyst Decision
  • XELB
  • INDP Strong Buy
  • Analyst Count
  • XELB 0
  • INDP 2
  • Target Price
  • XELB N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • XELB 146.4K
  • INDP 689.8K
  • Earning Date
  • XELB 08-13-2025
  • INDP 08-11-2025
  • Dividend Yield
  • XELB N/A
  • INDP N/A
  • EPS Growth
  • XELB N/A
  • INDP N/A
  • EPS
  • XELB N/A
  • INDP N/A
  • Revenue
  • XELB $7,407,000.00
  • INDP N/A
  • Revenue This Year
  • XELB $23.96
  • INDP N/A
  • Revenue Next Year
  • XELB $53.02
  • INDP N/A
  • P/E Ratio
  • XELB N/A
  • INDP N/A
  • Revenue Growth
  • XELB N/A
  • INDP N/A
  • 52 Week Low
  • XELB $1.60
  • INDP $7.56
  • 52 Week High
  • XELB $8.49
  • INDP $67.48
  • Technical
  • Relative Strength Index (RSI)
  • XELB 37.04
  • INDP 98.13
  • Support Level
  • XELB $1.60
  • INDP $0.31
  • Resistance Level
  • XELB $2.06
  • INDP $0.71
  • Average True Range (ATR)
  • XELB 0.18
  • INDP 0.07
  • MACD
  • XELB -0.01
  • INDP 0.77
  • Stochastic Oscillator
  • XELB 37.00
  • INDP 99.09

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: